Animas Corporation - Product Pipeline Analysis
Publisher Name » GlobalData
Published Date » 2012-06-14
No. Of Pages » 22
Animas Corporation - Product Pipeline Analysis
Summary
Animas Corporation (Animas) is a medical device company, based in the US. The company manufactures and distributes external insulin pumps and diabetes products to serve the diabetes patients. Its product portfolio includes insulin pumps, pump accessories, onetouch ping, dexcom seven plus cgm, continuous glucose monitoring (CGM) system and infusion systems. Animas provides diabetes management software such as ezManagerMax and Diasend. The company develops DexCom SEVEN PLUS CGM system through the joint development agreement with DexCom, Inc. It operates as a subsidiary of Johnson & Johnson. The company was incorporated in 1996. Animas is headquartered in West Chester, Pennsylvania, the US.
This report is a source for data, analysis and actionable intelligence on the Animas Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Summary
Animas Corporation (Animas) is a medical device company, based in the US. The company manufactures and distributes external insulin pumps and diabetes products to serve the diabetes patients. Its product portfolio includes insulin pumps, pump accessories, onetouch ping, dexcom seven plus cgm, continuous glucose monitoring (CGM) system and infusion systems. Animas provides diabetes management software such as ezManagerMax and Diasend. The company develops DexCom SEVEN PLUS CGM system through the joint development agreement with DexCom, Inc. It operates as a subsidiary of Johnson & Johnson. The company was incorporated in 1996. Animas is headquartered in West Chester, Pennsylvania, the US.
This report is a source for data, analysis and actionable intelligence on the Animas Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Animas Corporation - Major Products and Services 5
Animas Corporation Pipeline Products by Equipment Type 6
Animas Corporation Pipeline Products by Development Stage 8
Animas Corporation Pipeline Products by Therapy Area 10
Animas Corporation Pipeline Products by Trial Phase 12
Animas Corporation Pipeline Products by Milestone Summary 13
Animas Next Generation ONETOUCH Ping 14
Animas Next Generation ONETOUCH Ping Product Status 14
Animas Next Generation ONETOUCH Ping Product Description 14
Animas Vibe Insulin Pump and CGM System 15
Animas Vibe Insulin Pump and CGM System Product Status 15
Animas Vibe Insulin Pump and CGM System Product Description 15
Animas Vibe Insulin Pump and CGM System Product Milestone 15
Next Generation POC Testing System 17
Next Generation POC Testing System Product Status 17
Next Generation POC Testing System Product Description 17
Next Generation POC Testing System Version 1.5 18
Next Generation POC Testing System Version 1.5 Product Status 18
Next Generation POC Testing System Version 1.5 Product Description 18
Animas Corporation - Key Competitors 19
Animas Corporation - Key Employees 20
Animas Corporation - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
Animas Corporation, Key Facts 1
Animas Corporation Key Pipeline Products by Equipment Type 1
Animas Corporation Key Pipeline Products by Therapy Area 1
Animas Corporation Key Pipeline Products by Development Stage 1
Animas Corporation Key Pipeline Products by Trial Phase 1
Animas Corporation, Key Facts 4
Animas Corporation, Major Products and Services 5
Animas Corporation Number of Pipeline Products by Equipment Type 6
Animas Corporation Pipeline Products by Equipment Type 7
Animas Corporation Number of Pipeline Products by Development Stage 8
Animas Corporation Pipeline Products by Development Stage 9
Animas Corporation Number of Pipeline Products by Therapy Area 10
Animas Corporation Pipeline Products by Therapy Area 11
Animas Corporation Number of Pipeline Products by Trial Phase 12
Animas Corporation Pipeline Products by Trial Phase 12
Animas Corporation Number of Pipeline Products By Milestone Summary 13
Animas Corporation Pipeline Products by Milestone Summary 13
Animas Next Generation ONETOUCH Ping - Product Status 14
Animas Next Generation ONETOUCH Ping - Product Description 14
Animas Vibe Insulin Pump and CGM System - Product Status 15
Animas Vibe Insulin Pump and CGM System - Product Description 15
Animas Vibe Insulin Pump and CGM System - Product Milestone 15
Next Generation POC Testing System - Product Status 17
Next Generation POC Testing System - Product Description 17
Next Generation POC Testing System Version 1.5 - Product Status 18
Next Generation POC Testing System Version 1.5 - Product Description 18
Animas Corporation, Key Employees 20
Animas Corporation Key Pipeline Products by Equipment Type 1
Animas Corporation Pipeline Products by Equipment Type 6
Animas Corporation Pipeline Products by Development Stage 8
Animas Corporation Pipeline Products by Therapy Area 10
Animas Corporation Pipeline Products by Trial Phase 12
Animas Corporation Pipeline Products by Milestone Summary 13
Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Animas Corporation - Major Products and Services 5
Animas Corporation Pipeline Products by Equipment Type 6
Animas Corporation Pipeline Products by Development Stage 8
Animas Corporation Pipeline Products by Therapy Area 10
Animas Corporation Pipeline Products by Trial Phase 12
Animas Corporation Pipeline Products by Milestone Summary 13
Animas Next Generation ONETOUCH Ping 14
Animas Next Generation ONETOUCH Ping Product Status 14
Animas Next Generation ONETOUCH Ping Product Description 14
Animas Vibe Insulin Pump and CGM System 15
Animas Vibe Insulin Pump and CGM System Product Status 15
Animas Vibe Insulin Pump and CGM System Product Description 15
Animas Vibe Insulin Pump and CGM System Product Milestone 15
Next Generation POC Testing System 17
Next Generation POC Testing System Product Status 17
Next Generation POC Testing System Product Description 17
Next Generation POC Testing System Version 1.5 18
Next Generation POC Testing System Version 1.5 Product Status 18
Next Generation POC Testing System Version 1.5 Product Description 18
Animas Corporation - Key Competitors 19
Animas Corporation - Key Employees 20
Animas Corporation - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
List of TablesAnimas Corporation, Key Facts 1
Animas Corporation Key Pipeline Products by Equipment Type 1
Animas Corporation Key Pipeline Products by Therapy Area 1
Animas Corporation Key Pipeline Products by Development Stage 1
Animas Corporation Key Pipeline Products by Trial Phase 1
Animas Corporation, Key Facts 4
Animas Corporation, Major Products and Services 5
Animas Corporation Number of Pipeline Products by Equipment Type 6
Animas Corporation Pipeline Products by Equipment Type 7
Animas Corporation Number of Pipeline Products by Development Stage 8
Animas Corporation Pipeline Products by Development Stage 9
Animas Corporation Number of Pipeline Products by Therapy Area 10
Animas Corporation Pipeline Products by Therapy Area 11
Animas Corporation Number of Pipeline Products by Trial Phase 12
Animas Corporation Pipeline Products by Trial Phase 12
Animas Corporation Number of Pipeline Products By Milestone Summary 13
Animas Corporation Pipeline Products by Milestone Summary 13
Animas Next Generation ONETOUCH Ping - Product Status 14
Animas Next Generation ONETOUCH Ping - Product Description 14
Animas Vibe Insulin Pump and CGM System - Product Status 15
Animas Vibe Insulin Pump and CGM System - Product Description 15
Animas Vibe Insulin Pump and CGM System - Product Milestone 15
Next Generation POC Testing System - Product Status 17
Next Generation POC Testing System - Product Description 17
Next Generation POC Testing System Version 1.5 - Product Status 18
Next Generation POC Testing System Version 1.5 - Product Description 18
Animas Corporation, Key Employees 20
List of Figures
List of FiguresAnimas Corporation Key Pipeline Products by Equipment Type 1
Animas Corporation Pipeline Products by Equipment Type 6
Animas Corporation Pipeline Products by Development Stage 8
Animas Corporation Pipeline Products by Therapy Area 10
Animas Corporation Pipeline Products by Trial Phase 12
Animas Corporation Pipeline Products by Milestone Summary 13
Upcoming Reports:
|
Medical Aesthetics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Medical aesthetics is a branch of medical science that deals with the use of artificial organs and body parts for patients who have lost a body part or are in need of corrective surgery on a body part. The growth of the market is attributed by driving factors such as rising disposable incomes of consumers coupled with the rising trend of body altering and the growing number of customer focused aesthetic organizations.
Economic development in the Asia-Pacific region leading to rapid urbanization will act as an opportunity for the market helping in ensuring future...
|
|
Antibody Drugs Market, Global Forecast, Market Share, Size, Growth And Industry Analysis, 2012 - 2018
By - Transparency Market Research
Antibody drugs make use of the body’s own immune system to locate and eliminate cells which are responsible for the target disease. Antibody drugs have been successful in attracting the attention of researchers worldwide owing to their characteristic features such as fewer side effects and high efficacy in curing certain diseases which were previously untreatable.
Large scale research development is being conducted in the field of antibody drugs for the past two decades. By 2009, approximately 30 new antibody drugs were launched in the market. With an intention of...
|
|
Healthcare Supplies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018
By - Transparency Market Research
The global demand for healthcare supplies is expected to increase in the near future due to the growing population and the increasing need for better healthcare services. There is a rising demand for home healthcare facilities, which is a prominent reason for the growth of this market. Product innovation is also expected to contribute effectively and have an influence on the healthcare supplies industry. The increasing volume of patient care activity encouraged by an aging population and the rising incidences of diseases and disorders is promoting the growth of the healthcare supplies...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- Overview of international chemical market
- Russian market of microcredits and lending to SME in Russia
- Overview of furniture market
- Global and China Piano Industry Report, 2012-2013
- The Future of the Haircare Market in Czech Republic to 2017
- LTE Strategy 2013 - 2018
- Natural And Synthetic (Ethoxyquin, BHA, BHT) Animal Feed Antioxidants Market For Swine, Poultry, Cattle And Aquaculture - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Seed Treatment Market (Insecticides, Fungicides, Other Chemical And Nonchemical Treatment) For Corn, Soybean, Wheat, Canola, Cotton And Others - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|

